{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:08:08Z","timestamp":1779970088542,"version":"3.53.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["ID 2019B020202003"],"award-info":[{"award-number":["ID 2019B020202003"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.biopha.2022.113512","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T08:42:34Z","timestamp":1659602554000},"page":"113512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Aberrant peribiliary gland niche exacerbates fibrosis in primary sclerosing cholangitis and a potential therapeutic strategy"],"prefix":"10.1016","volume":"153","author":[{"given":"Shouyan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henglei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2022.113512_bib1","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2021.07.046","article-title":"Defining primary sclerosing cholangitis: results from an international primary sclerosing cholangitis study group consensus process","volume":"161","author":"Ponsioen","year":"2021","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.biopha.2022.113512_bib2","first-page":"2102","article-title":"Effects of human amnion-derived mesenchymal stem cells and conditioned medium in rats with sclerosing cholangitis","volume":"10","author":"Sugiura","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.biopha.2022.113512_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management","volume":"145","author":"Eaton","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.biopha.2022.113512_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061288","article-title":"Primary biliary cholangitis and primary sclerosing cholangitis: current knowledge of pathogenesis and therapeutics","volume":"10","author":"Park","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2022.113512_bib5","author":"Rawla","year":"2021","journal-title":"Primary Sclerosing Cholangitis, StatPearls, Treasure Island (FL)"},{"issue":"5","key":"10.1016\/j.biopha.2022.113512_bib6","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.30472","article-title":"Ductular reaction cells display an inflammatory profile and recruit neutrophils in alcoholic hepatitis","volume":"69","author":"Aguilar-Bravo","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2022.113512_bib7","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/hep.24590","article-title":"Multipotent stem\/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets","volume":"54","author":"Cardinale","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2022.113512_bib8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.32382","article-title":"Healthy peribiliary glands are necessary for successful liver transplantation","volume":"75","author":"Francis","year":"2022","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2022.113512_bib9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jhep.2015.06.018","article-title":"Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis","volume":"63","author":"Carpino","year":"2015","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113512_bib10","first-page":"317","article-title":"Recent developments in the management of idiopathic cholestatic liver disease","volume":"25","author":"Imam","year":"2012","journal-title":"Ann. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113512_bib11","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/hep.31211","article-title":"Targeted apoptosis of ductular reactive cells reduces hepatic fibrosis in a mouse model of cholestasis","volume":"72","author":"Azad","year":"2020","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.biopha.2022.113512_bib12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41419-021-03931-1","article-title":"Conditional depletion of macrophages ameliorates cholestatic liver injury and fibrosis via lncRNA-H19","volume":"12","author":"Tian","year":"2021","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.biopha.2022.113512_bib13","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/hep.31140","article-title":"Monocytes as potential mediators of pathogen-induced T-Helper 17 differentiation in patients with primary sclerosing cholangitis (PSC)","volume":"72","author":"Kunzmann","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2022.113512_bib14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2018.05.018","article-title":"Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice","volume":"69","author":"Guicciardi","year":"2018","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.biopha.2022.113512_bib15","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/gut.52.9.1363","article-title":"Glucocorticoid receptors are downregulated in hepatic T lymphocytes in rats with experimental cholangitis","volume":"52","author":"Tjandra","year":"2003","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.biopha.2022.113512_bib16","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.30348","article-title":"The epidermal growth factor receptor ligand amphiregulin protects from cholestatic liver injury and regulates bile acids synthesis","volume":"69","author":"Santamaria","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.113512_bib17","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3389\/fphar.2020.00813","article-title":"The potentiality of herbal remedies in primary sclerosing cholangitis: from in vitro to clinical studies","volume":"11","author":"Ceccherini","year":"2020","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2022.113512_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103804","article-title":"Synthesis and anti-hepaticfibrosis of glycyrrhetinic acid derivatives with inhibiting COX-2","volume":"99","author":"Zhang","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2022.113512_bib19","article-title":"The protective effect of glycyrrhetinic acid on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2022.113512_bib20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41419-021-03768-8","article-title":"Prevention of D-GalN\/LPS-induced ALI by 18beta-glycyrrhetinic acid through PXR-mediated inhibition of autophagy degradation","volume":"12","author":"Wu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.biopha.2022.113512_bib21","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1021\/jf405352g","article-title":"Glycyrrhetinic acid suppressed NF-kappaB activation in TNF-alpha-induced hepatocytes","volume":"62","author":"Chen","year":"2014","journal-title":"J. Agric. Food Chem."},{"issue":"43","key":"10.1016\/j.biopha.2022.113512_bib22","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.biopha.2022.113512_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet"},{"key":"10.1016\/j.biopha.2022.113512_bib24","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkm882","article-title":"KEGG for linking genomes to life and the environment","volume":"36","author":"Kanehisa","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.113512_bib25","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/gb-2010-11-2-r14","article-title":"Gene ontology analysis for RNA-seq: accounting for selection bias","volume":"11","author":"Young","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.biopha.2022.113512_bib26","article-title":"An improved method for isolation and flow cytometric characterization of intrahepatic leukocytes from fatty and fibrotic liver tissues","author":"Kandhi","year":"2022","journal-title":"Anat. Rec. (Hoboken)"},{"issue":"5","key":"10.1016\/j.biopha.2022.113512_bib27","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/andr.12816","article-title":"Blood plasma miR-20a-5p expression as a potential non-invasive diagnostic biomarker of male infertility: a pilot study","volume":"8","author":"Cito","year":"2020","journal-title":"Androl. -Us"},{"issue":"6","key":"10.1016\/j.biopha.2022.113512_bib28","first-page":"917","article-title":"Indole-3-propionic acid-aggravated CCl4-induced liver fibrosis via the TGF-beta1\/Smads signaling pathway","volume":"9","author":"Liu","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113512_bib29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12933-022-01564-y","article-title":"Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonist","volume":"21","author":"Phillips","year":"2022","journal-title":"Cardiovasc Diabetol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113512_bib30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2010.03.008","article-title":"Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis","volume":"53","author":"Sasaki","year":"2010","journal-title":"J. Hepatol."},{"issue":"4 Pt B","key":"10.1016\/j.biopha.2022.113512_bib31","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbadis.2017.06.027","article-title":"Animal models of biliary injury and altered bile acid metabolism","volume":"1864","author":"Mariotti","year":"2018","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"issue":"22","key":"10.1016\/j.biopha.2022.113512_bib32","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.3748\/wjg.v12.i22.3523","article-title":"Heterogeneity of the intrahepatic biliary epithelium","volume":"12","author":"Glaser","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.biopha.2022.113512_bib33","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41401-018-0110-y","article-title":"18 beta-Glycyrrhetinic acid protects against alpha-naphthylisothiocyanate-induced cholestasis through activation of the Sirt1\/FXR signaling pathway","volume":"39","author":"Wu","year":"2018","journal-title":"Acta Pharm. Sin."},{"issue":"6","key":"10.1016\/j.biopha.2022.113512_bib34","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/hep.25614","article-title":"Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis","volume":"55","author":"Sancho-Bru","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2022.113512_bib35","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1002\/hep.32028","article-title":"Mast cells regulate ductular reaction and intestinal inflammation in cholestasis through farnesoid X receptor signaling","volume":"74","author":"Meadows","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2022.113512_bib36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/path.5228","article-title":"High-throughput sequencing identifies aetiology-dependent differences in ductular reaction in human chronic liver disease","volume":"248","author":"Govaere","year":"2019","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113512_bib37","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.ajpath.2011.06.042","article-title":"Kupffer cells influence parenchymal invasion and phenotypic orientation, but not the proliferation, of liver progenitor cells in a murine model of liver injury","volume":"179","author":"Van Hul","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2022.113512_bib38","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.omtn.2019.12.035","article-title":"A comparative analysis of single-cell transcriptome identifies reprogramming driver factors for efficiency improvement","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"2","key":"10.1016\/j.biopha.2022.113512_bib39","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/IGC.0b013e3181c97ae0","article-title":"Transcription factor POU6F1 Is important for proliferation of clear cell adenocarcinoma of the ovary and is a potential new molecular target","volume":"20","author":"Suzuki","year":"2010","journal-title":"Int J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2022.113512_bib40","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"Krenkel","year":"2018","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.biopha.2022.113512_bib41","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2022.113512_bib42","first-page":"5450","article-title":"Protein which binds to the T-cell receptor-beta enhancer","volume":"13","author":"Messier","year":"1993","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113512_bib43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jb\/mvz088","article-title":"Aurora kinase A-mediated phosphorylation of mPOU at a specific site drives skeletal muscle differentiation","volume":"167","author":"Karthigeyan","year":"2020","journal-title":"J. Biochem"},{"issue":"1","key":"10.1016\/j.biopha.2022.113512_bib44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jhep.2020.02.033","article-title":"Investigators, a randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis","volume":"73","author":"Kowdley","year":"2020","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.biopha.2022.113512_bib45","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/17474124.2019.1636647","article-title":"Pharmacologic management of primary sclerosing cholangitis: what\u2019s in the pipeline?","volume":"13","author":"Suri","year":"2019","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113512_bib46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12072-020-10118-x","article-title":"Management of primary sclerosing cholangitis and its complications: an algorithmic approach","volume":"15","author":"Prokopic","year":"2021","journal-title":"Hepatol. Int."},{"issue":"3","key":"10.1016\/j.biopha.2022.113512_bib47","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.27074","article-title":"Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis","volume":"60","author":"Wunsch","year":"2014","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.biopha.2022.113512_bib48","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.dld.2021.04.028","article-title":"Treatment of primary sclerosing cholangitis","volume":"53","author":"Floreani","year":"2021","journal-title":"Dig. Liver Dis."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222009015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222009015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T11:44:13Z","timestamp":1779968653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222009015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":48,"alternative-id":["S0753332222009015"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113512","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant peribiliary gland niche exacerbates fibrosis in primary sclerosing cholangitis and a potential therapeutic strategy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113512"}}